OTCPK:FUAP.F

Stock Analysis Report

Global Cannabis Applications

Executive Summary

Global Cannabis Applications Corp. designs, develops, markets, and acquires data technologies for the medical cannabis industry.

Snowflake

Fundamentals

Mediocre balance sheet and overvalued.

Risks

  • Global Cannabis Applications has significant price volatility in the past 3 months.
  • Global Cannabis Applications is not covered by any analysts.

Share Price & News

How has Global Cannabis Applications's share price performed over time and what events caused price changes?


Latest Share Price and Events


Market Performance


7 Day Return

-15.0%

OTCPK:FUAP.F

2.1%

US Healthcare Services

1.1%

US Market


1 Year Return

-82.2%

OTCPK:FUAP.F

7.7%

US Healthcare Services

2.1%

US Market

FUAP.F underperformed the Healthcare Services industry which returned 6.6% over the past year.

FUAP.F underperformed the Market in United States of America which returned 2% over the past year.


Share holder returns

FUAP.FIndustryMarket
7 Day-15.0%2.1%1.1%
30 Day-15.0%-4.7%3.7%
90 Day-36.2%-4.6%2.3%
1 Year-82.2%-82.2%7.7%7.7%4.4%2.1%
3 Year-61.8%-61.8%51.1%50.8%47.0%37.4%
5 Yearn/a49.2%48.3%61.6%43.8%

Price Volatility Vs. Market

How volatile is Global Cannabis Applications's share price compared to the market and industry in the last 5 years?


Simply Wall St News

No news available

Valuation

Is Global Cannabis Applications undervalued based on future cash flows and its price relative to the stock market?

1.48x

Price to Book (PB) ratio


Intrinsic Value Based on Future Cash Flows

Unable to calculate intrinsic value for Global Cannabis Applications to establish if it is available at moderate discount.

Unable to calculate intrinsic value for Global Cannabis Applications to establish if it is available at substantial discount.


Price Based on Earnings

Global Cannabis Applications is loss making, we can't compare its value to the US Healthcare Services industry average.

Global Cannabis Applications is loss making, we can't compare the value of its earnings to the United States of America market.


Price Based on Expected Growth

Unable to calculate PEG ratio for Global Cannabis Applications, we can't assess if its growth is good value.


Price Based on Value of Assets

Global Cannabis Applications is good value based on assets compared to the US Healthcare Services industry average.


Next Steps

Future Growth

How is Global Cannabis Applications expected to perform in the next 1 to 3 years based on estimates from 0 analysts?

27.7%

Forecasted Healthcare industry annual growth in earnings


In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Global Cannabis Applications has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.

This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.


Next Steps

  • Take a look at our analysis of FUAP.F’s management and see if the CEO’s compensation is within a reasonable range, who is on the board and if insiders have been trading lately.
  • While we do not consider unaudited financials to be a reliable enough to include in our analysis, you can access them on the OTC Markets Website. If you are looking for more of a qualitative research into the company, you can access Global Cannabis Applications's filings and announcements here.
  • Explore growth companies in the Healthcare industry.

Past Performance

How has Global Cannabis Applications performed over the past 5 years?

-42.1%

Historical annual earnings growth


Earnings and Revenue History


Past Earnings Growth Analysis

Global Cannabis Applications does not make a profit and their year on year earnings growth rate was negative over the past 5 years.

Unable to compare Global Cannabis Applications's 1-year earnings growth to the 5-year average as it is not currently profitable.

Unable to compare Global Cannabis Applications's 1-year growth to the US Healthcare Services industry average as it is not currently profitable.


Return on Equity

It is difficult to establish if Global Cannabis Applications has efficiently used shareholders’ funds last year (Return on Equity greater than 20%) as it is loss-making.


Return on Assets

It is difficult to establish if Global Cannabis Applications has efficiently used its assets last year compared to the US Healthcare Services industry average (Return on Assets) as it is loss-making.


Return on Capital Employed

It is difficult to establish if Global Cannabis Applications improved its use of capital last year versus 3 years ago (Return on Capital Employed) as it is currently loss-making.


Next Steps

Financial Health

How is Global Cannabis Applications's financial position?


Financial Position Analysis

Global Cannabis Applications is able to meet its short term (1 year) commitments with its holdings of cash and other short term assets.

Global Cannabis Applications has no long term commitments.


Debt to Equity History and Analysis

Global Cannabis Applications's level of debt (11.8%) compared to net worth is satisfactory (less than 40%).

Unable to establish if Global Cannabis Applications's debt level has increased without past 5-year debt data.


Balance Sheet

Low level of unsold assets.

Debt is covered by short term assets, assets are 9.4x debt.


Cash Runway Analysis

For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.

Global Cannabis Applications has less than a year of cash runway based on current free cash flow.

Global Cannabis Applications has less than a year of cash runway if free cash flow continues to grow at historical rates of 73.5% each year.


Next Steps

Dividend

What is Global Cannabis Applications's current dividend yield, its reliability and sustainability?


Dividend Yield and Payments Analysis

Unable to evaluate Global Cannabis Applications's dividend yield against the bottom 25% of dividend payers as the company has not reported any payouts.

Unable to evaluate Global Cannabis Applications's dividend against the top 25% market benchmark as the company has not reported any payouts.

Unable to perform a dividend volatility check as Global Cannabis Applications has not reported any payouts.

Unable to verify if Global Cannabis Applications's dividend has been increasing as the company has not reported any payouts.


Current Payout to Shareholders

Unable to calculate sustainability of dividends as Global Cannabis Applications has not reported any payouts.


Future Payout to Shareholders

Insufficient estimate data to determine if a dividend will be paid in 3 years and that it will be sustainable.


Next Steps

Management

What is the CEO of Global Cannabis Applications's salary, the management and board of directors tenure and is there insider trading?

3.6yrs

Average management tenure


CEO

Brad Moore 0

3.6yrs

Tenure

CA$343,039

Compensation

Mr. Bradley Moore, also known as Brad, has been the Chief Executive Officer and Director at Global Cannabis Applications Corp. (formerly, Fundamental Applications Corp.) since February 03, 2016. Mr. Moore  ...


CEO Compensation Analysis

Brad's remuneration is lower than average for companies of similar size in United States of America.

Brad's compensation has increased whilst company is loss making.


Management Age and Tenure

3.6yrs

Average Tenure

The tenure for the Global Cannabis Applications management team is about average.


Board Age and Tenure

3.3yrs

Average Tenure

The tenure for the Global Cannabis Applications board of directors is about average.


Insider Trading

No 3 month open market individual insider trading information.


Ownership Breakdown


Management Team

  • Nick Miller (67yo)

    • Tenure: 4.3yrs
    • Compensation: CA$27.75k
  • Alex Helmel (49yo)

    CFO, Corporate Secretary & Director

    • Tenure: 4.3yrs
    • Compensation: CA$101.50k
  • Brad Moore

    CEO & Director

    • Tenure: 3.6yrs
    • Compensation: CA$343.04k
  • Tony G Guoga

    Advisor & Member of Initial Coin Offering Advisory Board

    • Tenure: 1.7yrs
  • Alon Tzipory

    Chief Operating Officer

    • Tenure: 0.8yrs
  • Hanan Gelbendorf

    Chief Marketing Officer

    • Tenure: 0yrs
  • Anastasija Plotnikova

    Chief Operating Officer of GCAC Europe

    • Tenure: 0yrs

Board Members

  • Alex Helmel (49yo)

    CFO, Corporate Secretary & Director

    • Tenure: 4.3yrs
    • Compensation: CA$101.50k
  • Brad Moore

    CEO & Director

    • Tenure: 3.6yrs
    • Compensation: CA$343.04k
  • Jeff Hayzlett

    Independent Director

    • Tenure: 3.1yrs
    • Compensation: CA$31.73k
  • Scott Walker

    Member of Advisory Board

    • Tenure: 0yrs
  • Tony G Guoga

    Advisor & Member of Initial Coin Offering Advisory Board

    • Tenure: 1.7yrs
  • Samuel, Sam Lee

    Member of Advisory Board

    • Tenure: 0yrs
  • Jonathan Grunfeld

    Member of Advisory Board

    • Tenure: 0yrs

Company Information

Global Cannabis Applications Corp.'s company bio, employee growth, exchange listings and data sources


Key Information

  • Name: Global Cannabis Applications Corp.
  • Ticker: FUAP.F
  • Exchange: OTCPK
  • Founded: 2014
  • Industry: Health Care Technology
  • Sector: Healthcare
  • Market Cap: CA$5.031m
  • Listing Market Cap: CA$3.797m
  • Shares outstanding: 100.62m
  • Website: https://cannappscorp.com

Location

  • Global Cannabis Applications Corp.
  • 1100 Melville Street
  • Suite 830
  • Vancouver
  • British Columbia
  • V6E 4A6
  • Canada

Listings

TickerExchangePrimary SecuritySecurity TypeCountryCurrencyListed on
APPCNSX (Canadian National Stock Exchange)YesCommon SharesCACADNov 2014
2FADB (Deutsche Boerse AG)YesCommon SharesDEEURNov 2014
FUAP.FOTCPK (Pink Sheets LLC)YesCommon SharesUSUSDNov 2014

Biography

Global Cannabis Applications Corp. designs, develops, markets, and acquires data technologies for the medical cannabis industry. It offers Citizen Green platform, an end to end platform for the collection, ...


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2019/09/17 00:40
End of Day Share Price2019/09/16 00:00
Earnings2019/03/31
Annual Earnings2018/06/30


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.